Total Payments
$7,884
2024 Payments
$422.64
Companies
35
Transactions
199
Medicare Patients
1,042
Medicare Billing
$107,609
Payment Breakdown by Category
Food & Beverage$4,373 (55.5%)
Consulting$2,800 (35.5%)
Travel$682.63 (8.7%)
Education$28.14 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,373 | 194 | 55.5% |
| Consulting Fee | $2,800 | 1 | 35.5% |
| Travel and Lodging | $682.63 | 2 | 8.7% |
| Education | $28.14 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $3,309 | 26 | $0 (2023) |
| Medtronic USA, Inc. | $922.18 | 9 | $0 (2020) |
| Biogen, Inc. | $420.98 | 8 | $0 (2022) |
| Genentech USA, Inc. | $390.75 | 11 | $0 (2023) |
| ABBVIE INC. | $379.57 | 34 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $264.63 | 6 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $262.79 | 8 | $0 (2023) |
| Eisai Inc. | $258.30 | 15 | $0 (2023) |
| ARGENX US, INC. | $200.87 | 10 | $0 (2023) |
| GENZYME CORPORATION | $159.36 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $422.64 | 27 | ABBVIE INC. ($183.98) |
| 2023 | $756.63 | 38 | UCB, Inc. ($222.05) |
| 2022 | $1,518 | 83 | UCB, Inc. ($251.04) |
| 2021 | $326.52 | 18 | Eisai Inc. ($51.30) |
| 2020 | $933.60 | 10 | Medtronic USA, Inc. ($922.18) |
| 2019 | $2,822 | 2 | UCB, Inc. ($2,800) |
| 2018 | $73.12 | 4 | Genentech USA, Inc. ($37.22) |
| 2017 | $1,032 | 17 | Biogen, Inc. ($318.38) |
All Payment Transactions
199 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.33 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.58 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.16 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $7.55 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.42 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.23 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.50 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: NEUROLOGY | ||||||
| 09/11/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.71 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $8.38 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $5.78 | General |
| Category: NEUROSCIENCE | ||||||
| 08/13/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Education | Cash or cash equivalent | $16.72 | General |
| Category: NEUROLOGY | ||||||
| 08/06/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.92 | General |
| Category: NEUROSCIENCE | ||||||
| 07/23/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.10 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $7.31 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.24 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.51 | General |
| Category: NEUROSCIENCE | ||||||
| 05/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.42 | General |
| Category: NEUROSCIENCE | ||||||
| 05/01/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.32 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.81 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 01/18/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 166 | 228 | $57,696 | $14,652 |
| 2022 | 8 | 318 | 433 | $134,594 | $37,099 |
| 2021 | 7 | 276 | 380 | $107,536 | $32,133 |
| 2020 | 9 | 282 | 341 | $84,524 | $23,725 |
Total Patients
1,042
Total Services
1,382
Medicare Billing
$107,609
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 63 | 113 | $33,674 | $8,410 | 25.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 19 | $7,619 | $2,334 | 30.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 29 | 32 | $5,184 | $1,372 | 26.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $6,384 | $1,230 | 19.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 14 | $2,828 | $710.58 | 25.1% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 11 | 11 | $1,782 | $385.83 | 21.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 22 | 25 | $225.00 | $210.00 | 93.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 93 | 190 | $53,476 | $16,063 | 30.0% |
| 95812 | Measurement of brain wave activity (eeg), 41-60 minutes | Office | 2022 | 35 | 35 | $37,330 | $8,687 | 23.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 41 | 41 | $17,660 | $4,615 | 26.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 79 | 88 | $13,333 | $3,646 | 27.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 31 | $6,022 | $1,917 | 31.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 12 | $4,556 | $1,531 | 33.6% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 13 | 13 | $2,028 | $573.04 | 28.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 22 | 23 | $189.00 | $68.19 | 36.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 92 | 177 | $48,498 | $16,102 | 33.2% |
| 95812 | Measurement of brain wave (eeg) activity, 41-60 minutes | Office | 2021 | 16 | 16 | $16,736 | $4,285 | 25.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 34 | 34 | $14,246 | $3,445 | 24.2% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 71 | 85 | $12,665 | $3,339 | 26.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 21 | 21 | $7,749 | $2,608 | 33.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 14 | 14 | $7,378 | $2,254 | 30.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 28 | 33 | $264.00 | $99.00 | 37.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 49 | 74 | $20,276 | $6,110 | 30.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 44 | 44 | $18,436 | $4,921 | 26.7% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 24 | 24 | $12,648 | $3,471 | 27.4% |
About Dr. Karylsa Torres Gomez, M.D
Dr. Karylsa Torres Gomez, M.D is a Neurology healthcare provider based in Weslaco, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2014. The National Provider Identifier (NPI) number assigned to this provider is 1689089468.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Karylsa Torres Gomez, M.D has received a total of $7,884 in payments from pharmaceutical and medical device companies, with $422.64 received in 2024. These payments were reported across 199 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($4,373).
As a Medicare-enrolled provider, Torres Gomez has provided services to 1,042 Medicare beneficiaries, totaling 1,382 services with total Medicare billing of $107,609. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Weslaco, TX
- Active Since 06/30/2014
- Last Updated 11/23/2024
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1689089468
Products in Payments
- ACTIVA (Device) $922.18
- Briviact (Drug) $445.49
- OCREVUS (Biological) $362.69
- EPIDIOLEX (Drug) $264.63
- Fycompa (Drug) $258.30
- AUSTEDO (Drug) $243.16
- UBRELVY (Drug) $242.68
- VYVGART (Drug) $168.80
- AUBAGIO (Drug) $141.69
- ACTHAR (Biological) $140.18
- NUPLAZID (Drug) $123.61
- TECFIDERA (Drug) $103.23
- ZINBRYTA (Biological) $100.00
- VALTOCO (Drug) $92.52
- QULIPTA (Drug) $85.83
- Xeomin (Biological) $81.97
- Aimovig (Biological) $71.71
- Fintepla (Drug) $69.23
- SYMPAZAN (Drug) $69.14
- EMGALITY (Drug) $68.02
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.